Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib + CAPEOX in advanced gastric cancer
NCT01130805Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Dec 2010
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in gastric cancer (GC), sponsored by Samsung Medical Center. Started Dec 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01130805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01130805.